ACRS logo
Aclaris Therapeutics, Inc.(ACRS)
Last print unknown agoAbout this dataData status
$3.48▲0.20 (6.10%)Stale · unknown old

ACRS SBC to Revenue

141.82%TTM

Retrieved:

ACRS FY SBC/Revenue%
ACRS FY SBC/Revenue960.29%-102.89%
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ACRS sbc to revenue history

Stock-based compensation as percentage of revenue. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Aclaris Therapeutics Inc SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
158.2418%
57.9915%
65.7365%
50.5479%
207.9574%
172.8942%
0%
198.7415%
857.3975%
0%
0%
0%
0%

Compare sbc to revenue

All ACRS financial metrics · ACRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.